How is the Unity Biotechnology Inc today?

The Unity Biotechnology Inc today is trading in the down by -6.98% at 0.80.

How has Unity Biotechnology Inc performed historically?

The Unity Biotechnology Inc is currently trading down -6.98% on an intraday basis in the past week the index rose 17.65%. The index has been down -54.80% in the past quarter and fell -44.06% in the past year. You can view this in the overview section.

What is Unity Biotechnology Inc Annual Net Profit?

Unity Biotechnology Inc Annual Net Profit rose 34.8% in the last year to $25.99 M. Its sector's average net profit growth for the last fiscal year was -13.89%.

What is Unity Biotechnology Inc Price to Earning Ratio?

Unity Biotechnology Inc Price to Earning Ratio is -0.5, which is negative.

What is Unity Biotechnology Inc Stock Price?

Unity Biotechnology Inc Stock Price fell 44.06% and underperformed its sector by 68.87% in the past year.

What is Unity Biotechnology Inc Quarterly Net profit?

Unity Biotechnology Inc Quarterly Net profit fell 26.11% YoY to $7.3 M. Its sector's average net profit growth YoY for the quarter was -238.55%.

What is Unity Biotechnology Inc Debt to Equity Ratio?

Unity Biotechnology Inc Debt to Equity Ratio of 3.62 is higher than 1. This implies that company assets are financed through debt.

What is Unity Biotechnology Inc Return on Equity(ROE)?

Unity Biotechnology Inc Return on Equity(ROE) for the last financial year was -148.97%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Unity Biotechnology Inc Mutual Fund Holding?

Unity Biotechnology Inc Mutual Fund Holding increased by 0.06% in the last quarter to 9.81.

What is Unity Biotechnology Inc Institutional Holding?

Unity Biotechnology Inc Institutional Holding decreased by 1.33% in the last quarter to 17.87.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
UNITY BIOTECHNOLOGY INC

Unity Biotechnology Inc XNAS: UBX

Unity Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Name: Unity Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Unity Biotechnology Inc
Rating: 0.76250
Author: Trendlyne DVM scores

about

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clea...

0.80 -0.06 (-6.98%)

74.19% Fall from 52W High

166.8K

XNAS Volume

High vol.+gain this week

XNAS 13 Jun, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Unity Biotechnology Inc is on 20 Jun 2025 for the purpose of Unity Biotechnology Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

30.5 / 100

No estimates available

Unity Biotechnology Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Unity Biotechnology Inc Live Share Price Today, Share Analysis and Chart

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clea...

74.19% Fall from 52W High

High vol.+gain this week

SWOT Analysis

Unity Biotechnology Inc Live Price Chart

Unity Biotechnology Inc FAQ

How is Unity Biotechnology Inc today?

Unity Biotechnology Inc today is trading in the red, and is down by -6.98% at 0.80.

How has Unity Biotechnology Inc performed historically?

Unity Biotechnology Inc is currently trading down -6.98% on an intraday basis. In the past week the stock rose 17.65%. stock has been down -54.80% in the past quarter and fell -44.06% in the past year. You can view this in the overview section.